Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:212-218

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorn, G. W.
Right arrow Articles by Halushka, P. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorn, G. W., 2d
Right arrow Articles by Halushka, P. V.

Circulation, Vol 81, 212-218, Copyright © 1990 by American Heart Association


ARTICLES

Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction

GW Dorn 2d, N Liel, JL Trask, DE Mais, ME Assey and PV Halushka
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC 29425.

Platelets have been implicated in the formation of occlusive intracoronary thrombi leading to unstable angina pectoris and acute myocardial infarction. Evidence of platelet involvement in these syndromes includes increased thromboxane A2 synthesis during ischemic events and enhanced in vitro sensitivity to agonists. To determine the density and affinity of platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in patients with acute myocardial infarction and unstable angina pectoris, the maximum number of binding sites (Bmax) per platelet and the dissociation constant (Kd) of the TXA2/PGH2 receptor antagonist, [125I]-PTA-OH, was determined at equilibrium in washed platelets. Patients with acute myocardial infarction had a significantly (p = 0.006) higher Bmax (4,468 +/- 672 sites/platelet, n = 9) compared with controls (2,206 +/- 203 sites/platelet, n = 8). Restudied at a time when the patients' coronary artery disease was clinically stable, Bmax values for the myocardial infarction group had returned to within normal limits. The dissociation constant for [125I]- PTA-OH was not significantly different in the acute myocardial infarction patients compared with controls. In patients with acute myocardial infarction, the duration of chest pain was positively correlated (r = 0.71, p less than 0.02) with the number of [125I]-PTA- OH binding sites (Bmax). In vitro platelet sensitivity to the TXA2/PGH2 mimetic, U46619, was assessed in aggregation studies. The maximal velocity of aggregation (slope) correlated with platelet TXA2/PGH2 receptor number (r = 0.67, p less than 0.001) and was significantly higher (p less than 0.02) in the acute myocardial infarction patients compared with the other study groups. There was no significant difference in the aggregation EC50 values for the thromboxane mimetic U46619 between unstable angina, acute myocardial infarction, and control groups.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. J. Wilson, C. C. Cavanagh, A. M. Lesher, A. J. Frey, S. E. Russell, and E. M. Smyth
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
J. Lipid Res., June 1, 2009; 50(6): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
P. D. Patel and R. R. Arora
Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease
Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 89 - 100.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
E. Hamelin, C. Theriault, G. Laroche, and J.-L. Parent
The Intracellular Trafficking of the G Protein-coupled Receptor TP{beta} Depends on a Direct Interaction with Rab11
J. Biol. Chem., October 28, 2005; 280(43): 36195 - 36205.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
A.A.L. Ajayi and P.V. Halushka
Castration reduces platelet thromboxane A2 receptor density and aggregability
QJM, May 1, 2005; 98(5): 349 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Gao, S. Tang, S. Zhou, and J. A. Ware
The Thromboxane A2 Receptor Activates Mitogen-Activated Protein Kinase via Protein Kinase C-Dependent Gi Coupling and Src-Dependent Phosphorylation of the Epidermal Growth Factor Receptor
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 426 - 433.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
Y. Gao, R. Yokota, S. Tang, A. W. Ashton, and J. A. Ware
Reversal of Angiogenesis In Vitro, Induction of Apoptosis, and Inhibition of Akt Phosphorylation in Endothelial Cells by Thromboxane A2
Circ. Res., October 27, 2000; 87(9): 739 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Manganello, Y. Djellas, C. Borg, K. Antonakis, and G. C. Le Breton
Cyclic AMP-dependent Phosphorylation of Thromboxane A2 Receptor-associated Galpha 13
J. Biol. Chem., September 24, 1999; 274(39): 28003 - 28010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Djellas, J. M. Manganello, K. Antonakis, and G. C. Le Breton
Identification of Galpha 13 as One of the G-proteins That Couple to Human Platelet Thromboxane A2 Receptors
J. Biol. Chem., May 14, 1999; 274(20): 14325 - 14330.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-Ph. Zucker, D. Bonisch, S. Muck, A.-A. Weber, E. Bretschneider, E. Glusa, and K. Schror
Thrombin-Induced Mitogenesis in Coronary Artery Smooth Muscle Cells Is Potentiated by Thromboxane A2 and Involves Upregulation of Thromboxane Receptor mRNA
Circulation, February 17, 1998; 97(6): 589 - 595.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Sasaki, T. Takahashi, I. Tanaka, K. Nakamura, Y. Okuno, O. Nakagawa, S. Narumiya, and K. Nakao
Expression of Prostacyclin Receptor in Human Megakaryocytes
Blood, August 1, 1997; 90(3): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yukawa, R. Yokota, R. T. Eberhardt, L. von Andrian, and J. A. Ware
Differential Desensitization of Thromboxane A2 Receptor Subtypes
Circ. Res., April 19, 1997; 80(4): 551 - 556.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. D. D'Angelo, B. G. Oliver, M. G. Davis, T. S. McCluskey, and G. W. Dorn II
Novel Role for Sp1 in Phorbol Ester Enhancement of Human Platelet Thromboxane Receptor Gene Expression
J. Biol. Chem., August 16, 1996; 271(33): 19696 - 19704.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. D. D'Angelo, M. G. Davis, W. A. Houser, J. J. Eubank, M. E. Ritchie, and G. W. Dorn II
Characterization of 5' End of Human Thromboxane Receptor Gene : Organizational Analysis and Mapping of Protein Kinase C– Responsive Elements Regulating Expression in Platelets
Circ. Res., September 1, 1995; 77(3): 466 - 474.
[Abstract] [Full Text]


Home page
CirculationHome page
A. A. L. Ajayi, R. Mathur, and P. V. Halushka
Testosterone Increases Human Platelet Thromboxane A2 Receptor Density and Aggregation Responses
Circulation, June 1, 1995; 91(11): 2742 - 2747.
[Abstract] [Full Text]


Home page
NEJMHome page
J. A. Ware and D. D. Heistad
Platelet-Endothelium Interactions
N. Engl. J. Med., March 4, 1993; 328(9): 628 - 635.
[Full Text]